Live: Will Constellation Brands Smash Q1 Earnings After the Bell Tonight?

Health and Healthcare

Merck : MRK

All Merck Articles

1083 Articles

Jon C. Ogg | Jan 7, 2014 at 8:51 AM EST

The Bullish and Bearish Case for Pfizer and Merck in 2014

With a new year comes new expectations. 24/7 Wall St. has generated a bullish and bearish scenario for 2014 in…

Jon C. Ogg | Dec 11, 2013 at 11:00 AM EST

Big Short Interest Changes in High-Yield Dividend Stocks

courtesy of VerizonThe short interest data for the end of November is out, and the results are somewhat surprising when it…

Jon C. Ogg | Dec 4, 2013 at 11:55 AM EST

Meet the Preliminary 2014 Dogs of the Dow: Dividends Galore

ThinkstockThere is a trend at the end of each year followed by many income investors. This is the Dogs of…

Jon C. Ogg | Nov 21, 2013 at 7:55 AM EST

Eight Big Dividend Hikes Expected Before 2013 Ends

ThinkstockInvestors love dividends, particularly safe and dependable dividends that rise through time. The S&P 500 Index currently has the most…

Jon C. Ogg | Nov 19, 2013 at 11:50 AM EST

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies…

Jon C. Ogg | Nov 18, 2013 at 2:16 PM EST

Merck Scores in Investigational Melanoma Study Results

ThinkstockSkin cancer treatments remain elusive. While some drugs are on the market for advanced-stage treatment, the most common and longest…

Lee Jackson | Nov 13, 2013 at 8:25 AM EST

UBS Top Stocks to Buy for 2014: GE, GM, Citigroup and Six More

While the past two years were all about getting the house back in order, the UBS equity strategy team thinks…

Jon C. Ogg | Nov 12, 2013 at 9:00 AM EST

Short Sellers Made Big Changes in High-Yield Dividend Stocks

We have now seen the short interest reports from the October 31 settlement date and have compared them to the…

Douglas A. McIntyre | Nov 9, 2013 at 8:30 AM EST

The Six Companies Cutting the Most Jobs in October

ThinkstockThe unemployment situation in the United States looked relatively good through the first half of the year. The jobless rate…

Douglas A. McIntyre | Nov 8, 2013 at 6:52 AM EST

Can U.S. Add Two Million Jobs This Year?

ThinkstockOctober’s jobs report showed a gain of 204,000 people to nonfarm payrolls. That is a pace of 1.5 million job additions…

Jon C. Ogg | Oct 30, 2013 at 8:05 AM EDT

Top Analyst Upgrades and Downgrades: BP, 3D Systems, Nike, SanDisk and More

Jon OggInvestors are having to deal with seeing stocks hit new highs almost daily now. With a temporary deal in…

Jon C. Ogg | Oct 28, 2013 at 1:19 PM EDT

Merck Sets Low Earnings Bar for Pfizer

The drug patent cliff for Big Pharma is coming with some continued consequences, and two drug giants with earnings this…

Paul Ausick | Oct 28, 2013 at 7:50 AM EDT

Merck Continues to Face Revenue Challenges

ThinkstockDrug giant Merck & Co. Inc. (NYSE: MRK) reported third-quarter 2013 results before markets opened Monday morning. The company posted…

Douglas A. McIntyre | Oct 28, 2013 at 6:46 AM EDT

A New Rise in Global Mergers/Buyouts

courtesy of Verizon WirelessMergers and acquisitions (M&A) sometimes can be an excellent measure of the economy’s financial health. However, since…

Jon C. Ogg | Oct 27, 2013 at 8:38 AM EDT

The 10 Most Important Earnings in the Week Ahead

Jon OggEarnings season is in full swing and this coming week will bring many key earnings reports. This will also…

1 … 50 51 52 53 54 … 73

Merck : MRK

All Merck Articles

The Bullish and Bearish Case for Pfizer and Merck in 2014

Big Short Interest Changes in High-Yield Dividend Stocks

Meet the Preliminary 2014 Dogs of the Dow: Dividends Galore

Eight Big Dividend Hikes Expected Before 2013 Ends

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Merck Scores in Investigational Melanoma Study Results

UBS Top Stocks to Buy for 2014: GE, GM, Citigroup and Six More

Short Sellers Made Big Changes in High-Yield Dividend Stocks

The Six Companies Cutting the Most Jobs in October

Can U.S. Add Two Million Jobs This Year?

Top Analyst Upgrades and Downgrades: BP, 3D Systems, Nike, SanDisk and More

Merck Sets Low Earnings Bar for Pfizer

Merck Continues to Face Revenue Challenges

A New Rise in Global Mergers/Buyouts

The 10 Most Important Earnings in the Week Ahead

Live: Will Constellation Brands Smash Q1 Earnings After the Bell Tonight?

Live: Will Nike Crush Q4 Earnings and Continue Their Turnaround Tonight?

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

You’re 30 with Little Saved, but $500 a Month in These 3 ETFs Might Make You a Millionaire

AI Isn’t Killing Jobs. New Study Finds Companies That Use AI Most Are Leading a Hiring Boom.

Her Husband Handled the Medicare Paperwork. After He Died, Her Premium Doubled Overnight.

A 66-Year-Old With $1.1 Million in Her IRA Owes the IRS More Than She Thinks

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

You’re 30 with Little Saved, but $500 a Month in These 3 ETFs Might Make You a Millionaire

Merck : MRK

All Merck Articles

The Bullish and Bearish Case for Pfizer and Merck in 2014

Big Short Interest Changes in High-Yield Dividend Stocks

Meet the Preliminary 2014 Dogs of the Dow: Dividends Galore

Eight Big Dividend Hikes Expected Before 2013 Ends

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Merck Scores in Investigational Melanoma Study Results

UBS Top Stocks to Buy for 2014: GE, GM, Citigroup and Six More

Short Sellers Made Big Changes in High-Yield Dividend Stocks

The Six Companies Cutting the Most Jobs in October

Can U.S. Add Two Million Jobs This Year?

Top Analyst Upgrades and Downgrades: BP, 3D Systems, Nike, SanDisk and More

Merck Sets Low Earnings Bar for Pfizer

Merck Continues to Face Revenue Challenges

A New Rise in Global Mergers/Buyouts

The 10 Most Important Earnings in the Week Ahead

Live: Will Constellation Brands Smash Q1 Earnings After the Bell Tonight?

Live: Will Nike Crush Q4 Earnings and Continue Their Turnaround Tonight?

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

You’re 30 with Little Saved, but $500 a Month in These 3 ETFs Might Make You a Millionaire

AI Isn’t Killing Jobs. New Study Finds Companies That Use AI Most Are Leading a Hiring Boom.

Featured Reads

Her Husband Handled the Medicare Paperwork. After He Died, Her Premium Doubled Overnight.

A 66-Year-Old With $1.1 Million in Her IRA Owes the IRS More Than She Thinks